Follow
Alejandro Campos, M.D.
Alejandro Campos, M.D.
Internal Medicine Resident, BMC; Clinical Research Fellow, Framingham Heart Study, Boston University
Verified email at bu.edu
Title
Cited by
Cited by
Year
Weight loss outcomes associated with semaglutide treatment for patients with overweight or obesity
W Ghusn, A De la Rosa, D Sacoto, L Cifuentes, A Campos, F Feris, ...
JAMA Network Open 5 (9), e2231982-e2231982, 2022
732022
Integrative hedonic and homeostatic food intake regulation by the central nervous system: insights from neuroimaging
A Campos, JD Port, A Acosta
Brain sciences 12 (4), 431, 2022
332022
Effectiveness of anti-obesity medications approved for long-term use in a multidisciplinary weight management program: a multi-center clinical experience
G Calderon, D Gonzalez-Izundegui, KL Shan, OA Garcia-Valencia, ...
International Journal of Obesity 46 (3), 555-563, 2022
252022
Effects of heterozygous variants in the leptin-melanocortin pathway on Roux-en-Y gastric bypass outcomes: a 15-Year case–control study
A Campos, L Cifuentes, A Hashem, B Busebee, MD Hurtado-Andrade, ...
Obesity surgery 32 (8), 2632-2640, 2022
222022
Phenotype tailored lifestyle intervention on weight loss and cardiometabolic risk factors in adults with obesity: a single-centre, non-randomised, proof-of-concept study
L Cifuentes, W Ghusn, F Feris, A Campos, D Sacoto, A De la Rosa, ...
EClinicalMedicine 58, 2023
202023
Association of gastric emptying with postprandial appetite and satiety sensations in obesity
D Gonzalez‐Izundegui, A Campos, G Calderon, ML Ricardo‐Silgado, ...
Obesity, 2021
172021
Association between anxiety and eating behaviors in patients with obesity
L Cifuentes, A Campos, MLR Silgado, S Kelpin, J Stutzman, MD Hurtado, ...
Obesity Pillars 3, 100021, 2022
132022
Association between food intake and gastrointestinal symptoms in patients with obesity
W Ghusn, L Cifuentes, A Campos, D Sacoto, A De La Rosa, F Feris, ...
Gastro hep advances 2 (1), 121-128, 2023
52023
Cardiovascular risk and diseases in patients with and without leptin-melanocortin pathway variants
L Cifuentes, A Campos, D Sacoto, W Ghusn, A De la Rosa, F Feris, ...
Mayo Clinic Proceedings 98 (4), 533-540, 2023
42023
A comparison between weight loss outcomes with anti-obesity medications before and during Covid-19 pandemic at a tertiary weight management center
A De la Rosa, W Ghusn, D Sacoto, A Campos, L Cifuentes, F Feris, ...
Obesity Pillars 4, 100046, 2022
42022
Effect of caloric intake and macronutrient composition on intestinal cholesterol absorption and bile acids in patients with obesity
AM Hashem, L Cifuentes, G Calderon, ML Ricardo-Silgado, ...
American Journal of Physiology-Gastrointestinal and Liver Physiology 323 (3 …, 2022
32022
Weight loss and cardiovascular disease risk outcomes of semaglutide: a one-year multicentered study
W Ghusn, S Fansa, D Anazco, E Tama, B Nicolalde, K Gala, A De la Rosa, ...
International Journal of Obesity, 1-6, 2024
22024
Sex as an independent variable in the measurement of satiation: a retrospective cohort study
MD Hurtado, L Cifuentes, A Campos, A De La Rosa, E Kapoor, ...
International Journal of Obesity 46 (12), 2156-2162, 2022
22022
Type 2 Diabetes Remission in Patients with Heterozygous Variants in the Leptin-Melanocortin Pathway after Roux-en-Y Gastric Bypass: A Matched Case–Control Study
D Anazco, W Ghusn, A Campos, L Cifuentes, S Fansa, E Tama, JT Bublitz, ...
Obesity Surgery 33 (11), 3502-3509, 2023
12023
The effect of heterozygous gene variants of the leptin-melanocortin pathway on weight loss following sleeve gastrectomy
F Feris, W Ghusn, A Campos, L Cifuentes, A De la Rosa, D Sacoto, ...
Obesity Surgery 33 (7), 2246-2249, 2023
12023
Su563 THE IMPACT OF DIETARY CALORIC AND MACRONUTRIENTS COMPOSITION ON INTESTINAL CHOLESTEROL ABSORPTION, FECAL BILE AND FAT EXCRETION: A DEEPER INSIGHT INTO CHOLESTEROL …
A Hashem, G Calderon, MLR Silgado, A Campos, L Cifuentes, S Franks, ...
Gastroenterology 160 (6), S-740, 2021
12021
Su1945 NEURAL FOOTPRINTS OF THE VISCERAL, HOMEOSTATIC, AND HEDONIC COMPONENTS OF FOOD INTAKE REGULATION IN HUMANS: THE PHYSIOLOGICAL REGULATION OF ENERGY INTAKE (FOOD-PRINT …
A Campos, D Anazco, W Ghusn, S Fansa, K Al Annan, M Schaefer, ...
Gastroenterology 166 (5), S-879-S-880, 2024
2024
Sa1951 CLINICAL PARAMETERS ASSOCIATED WITH SEMAGLUTIDE INTOLERANCE IN PATIENTS WITH DIABETES AND OBESITY
W Ghusn, D Anazco, S Fansa, E Tama, L Cifuentes, A Campos, K Gala, ...
Gastroenterology 166 (5), S-591-S-592, 2024
2024
1283 SATIATION TESTING AND A SURROGATE MACHINE-LEARNING ASSISTED GENE RISK SCORE BIOMARKER PREDICT DIFFERENTIAL RESPONSES TO LIFESTYLE INTERVENTIONS: A POST-HOC ANALYSIS OF A …
D Anazco, L Cifuentes, S Fansa, W Ghusn, A Campos, E Tama, K Gala, ...
Gastroenterology 166 (5), S-306-S-307, 2024
2024
The association between previous use of anti‐obesity medication and semaglutide weight loss outcomes
W Ghusn, S Fansa, D Anazco, E Tama, L Cifuentes, K Gala, ...
Diabetes, Obesity and Metabolism, 2024
2024
The system can't perform the operation now. Try again later.
Articles 1–20